Search research articles
Contact Us
Filters
Showing results (31-40 of 67) with videos related to
Page
of 7
Sort By:
Blood Neoplasia
|
July 30, 2025
Targeting HASPIN kinase disrupts SR protein-mediated RNA splicing and synergizes with BCL-2 inhibitor venetoclax in AML
Mengdan Liu, Ming Yan, Amanda G Davis, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer
|
December 1, 2010
Effect of eszopiclone on sleep, fatigue, and pain in patients with mucositis associated with hematologic malignancies
Joel E Dimsdale, Edward D Ball, Ewa Carrier, et al.
British Journal of Haematology
|
July 7, 2015
Novel FNDC3B and MECOM fusion and WT1 L378fs* 7 frameshift mutation in an acute myeloid leukaemia patient with cytomorphological and immunophenotypic features reminiscent of acute promyelocytic leukaemia
Huan-You Wang, Caitlin McMahon, Siraj M Ali, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
November 19, 2002
Sequential modulation of growth factors: a novel strategy for adoptive immunotherapy of acute myeloid leukemia
Rui-Kun Zhong, Laura Z Rassenti, Thomas J Kipps, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
March 25, 2018
A Phase I/II Trial of the Combination of Azacitidine and Gemtuzumab Ozogamicin for Treatment of Relapsed Acute Myeloid Leukemia
Bruno C Medeiros, Tiffany N Tanaka, Larisa Balaian, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
August 17, 2010
Novel H1N1 influenza in hematopoietic stem cell transplantation recipients: two centers' experiences
Luis Espinosa-Aguilar, Jaime S Green, Graeme N Forrest, et al.
Transfusion
|
December 31, 2013
Prophylactic red blood cell exchange for ABO-mismatched hematopoietic progenitor cell transplants
Robyn Cunard, Isagani I Marquez, Edward D Ball, et al.
Cancer
|
July 1, 2011
Phase 2 randomized study of p53 antisense oligonucleotide (cenersen) plus idarubicin with or without cytarabine in refractory and relapsed acute myeloid leukemia
Jorge Cortes, Hagop Kantarjian, Edward D Ball, et al.
Journal of Computational Biology : a Journal of Computational Molecular Cell Biology
|
April 7, 2015
A scalable method for molecular network reconstruction identifies properties of targets and mutations in acute myeloid leukemia
Edison Ong, Anthony Szedlak, Yunyi Kang, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
August 18, 2010
CTLA-4 blockade following relapse of malignancy after allogeneic stem cell transplantation is associated with T cell activation but not with increased levels of T regulatory cells
Jiehua Zhou, Asad Bashey, Ruikun Zhong, et al.
Page
of 7
Search research articles
Search
Showing results (31-40 of 67) with videos related to
Sort By:
Page
of 7
Blood Neoplasia
|
July 30, 2025
Targeting HASPIN kinase disrupts SR protein-mediated RNA splicing and synergizes with BCL-2 inhibitor venetoclax in AML
Mengdan Liu, Ming Yan, Amanda G Davis, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer
|
December 1, 2010
Effect of eszopiclone on sleep, fatigue, and pain in patients with mucositis associated with hematologic malignancies
Joel E Dimsdale, Edward D Ball, Ewa Carrier, et al.
British Journal of Haematology
|
July 7, 2015
Novel FNDC3B and MECOM fusion and WT1 L378fs* 7 frameshift mutation in an acute myeloid leukaemia patient with cytomorphological and immunophenotypic features reminiscent of acute promyelocytic leukaemia
Huan-You Wang, Caitlin McMahon, Siraj M Ali, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
November 19, 2002
Sequential modulation of growth factors: a novel strategy for adoptive immunotherapy of acute myeloid leukemia
Rui-Kun Zhong, Laura Z Rassenti, Thomas J Kipps, et al.
Clinical Lymphoma, Myeloma & Leukemia
|
March 25, 2018
A Phase I/II Trial of the Combination of Azacitidine and Gemtuzumab Ozogamicin for Treatment of Relapsed Acute Myeloid Leukemia
Bruno C Medeiros, Tiffany N Tanaka, Larisa Balaian, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
August 17, 2010
Novel H1N1 influenza in hematopoietic stem cell transplantation recipients: two centers' experiences
Luis Espinosa-Aguilar, Jaime S Green, Graeme N Forrest, et al.
Transfusion
|
December 31, 2013
Prophylactic red blood cell exchange for ABO-mismatched hematopoietic progenitor cell transplants
Robyn Cunard, Isagani I Marquez, Edward D Ball, et al.
Cancer
|
July 1, 2011
Phase 2 randomized study of p53 antisense oligonucleotide (cenersen) plus idarubicin with or without cytarabine in refractory and relapsed acute myeloid leukemia
Jorge Cortes, Hagop Kantarjian, Edward D Ball, et al.
Journal of Computational Biology : a Journal of Computational Molecular Cell Biology
|
April 7, 2015
A scalable method for molecular network reconstruction identifies properties of targets and mutations in acute myeloid leukemia
Edison Ong, Anthony Szedlak, Yunyi Kang, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
August 18, 2010
CTLA-4 blockade following relapse of malignancy after allogeneic stem cell transplantation is associated with T cell activation but not with increased levels of T regulatory cells
Jiehua Zhou, Asad Bashey, Ruikun Zhong, et al.
Page
of 7